Large-scale testing (Phase 3)Study completedNCT02141399What this trial is testingA Long-Term Safety Study of ALKS 5461Who this might be right forMajor Depressive Disorder Alkermes, Inc. 1,485
Not applicableWithdrawnNCT06769555What this trial is testingBCMA/CD3 BiTE for RRAL or NDAL Amyloidosis With Insufficient Depth of Hematologic Response After Induction TherapyWho this might be right forAL Amyloidosis Institute of Hematology & Blood Diseases Hospital, China
Large-scale testing (Phase 3)Study completedNCT00891020What this trial is testingTocilizumab in Patients With Moderate to Severe Active Rheumatoid Arthritis Who Have an Inadequate Response to or Are Unable to Tolerate Biologic and Non-Biologic Disease-modifying Antirheumatic Drugs (DMARDs)Who this might be right forRheumatoid Arthritis Hoffmann-La Roche 886
Large-scale testing (Phase 3)UnknownNCT05090410What this trial is testingEfficacy and Safety of Selective JAK 1 Inhibitor Filgotinib in Active Rheumatoid Arthritis Patients With Inadequate Response to MethotrexateWho this might be right forRheumatoid ArthritisJAK InhibitorIL-6 Inhibitor+2 more Atsushi Kawakami 400
Large-scale testing (Phase 3)Study completedNCT01063062What this trial is testingA Study With Tocilizumab [RoActemra/Actemra] Monotherapy or in Combination With Methotrexate in Patients With Rheumatoid Arthritis (PICTURE)Who this might be right forRheumatoid Arthritis Hoffmann-La Roche 107
Not applicableStudy completedNCT01592292What this trial is testingAn Observational Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis And Inadequate Response Or Intolerance to a First Anti-TNF Alpha TherapyWho this might be right forRheumatoid Arthritis Hoffmann-La Roche 90
Post-approval studies (Phase 4)Study completedNCT01000610What this trial is testingMabThera (Rituximab) in Patients With Rheumatoid Arthritis and an Inadequate Response to MethotrexateWho this might be right forRheumatoid Arthritis Hoffmann-La Roche 18
Large-scale testing (Phase 3)Study completedNCT01173120What this trial is testingMethotrexate - Inadequate Response Device Sub-StudyWho this might be right forRheumatoid Arthritis (RA) Bristol-Myers Squibb 62
Post-approval studies (Phase 4)Study completedNCT00325689What this trial is testingAripiprazole Used as Dual Therapy in the Treatement of Patients With Chronic Stable Schizophrenia or Schizoaffective Disorder.Who this might be right forSchizophreniaSchizoaffective Disorder Otsuka Pharmaceutical Development & Commercialization, Inc. 323
Large-scale testing (Phase 3)Study completedNCT02706847What this trial is testingCompare Upadacitinib (ABT-494) to Placebo in Adults With Rheumatoid Arthritis on Stable Dose of Conventional Synthetic Disease-Modifying Antirheumatic Drugs (csDMARDs) With an Inadequate Response or Intolerance to Biologic DMARDsWho this might be right forRheumatoid Arthritis AbbVie 499
Large-scale testing (Phase 3)Study completedNCT01197755What this trial is testingEvaluation of Effectiveness of Two Dosing Regimens of Fostamatinib Compared to Placebo in Patients With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate and Have Had Inadequate Response to Single TNF-alpha AntagonistWho this might be right forRheumatoid Arthritis AstraZeneca 323
Not applicableUnknownNCT04438642What this trial is testingBiological and Esthetic Evaluation of Ceramic Onlay With Different Preparation DesignsWho this might be right forUnsatisfactory Restoration of ToothCarious Teeth Ahmed Adel Mahmoud Gadallah 38
Large-scale testing (Phase 3)Study completedNCT01244958What this trial is testingAddition of Rituximab to Leflunomide in Patients With Active Rheumatoid ArthritisWho this might be right forRheumatoid Arthritis Frank Behrens 156
Early research (Phase 1)Study completedNCT02819726What this trial is testingPK, PD, Safety, and Efficacy of SAIT101 Versus MabThera® Versus Rituxan® in Patients With Rheumatoid ArthritisWho this might be right forRheumatoid Arthritis Archigen Biotech Limited 294
Testing effectiveness (Phase 2)Study completedNCT01399008What this trial is testingSafety/Efficacy Study to Evaluate of MBX-102 in Combination With Allopurinol in Gout PatientsWho this might be right forGout Gilead Sciences 100
Large-scale testing (Phase 3)Study completedNCT03522415What this trial is testingStudy of Safety and Efficacy of HLX01+MTX in Patients With Rheumatoid ArthritisWho this might be right forModerately to Severely Active Rheumatoid Arthritis Shanghai Henlius Biotech 275
Large-scale testing (Phase 3)Looking for participantsNCT07090759What this trial is testingTo Evaluate the Efficacy, Safety and Population Pharmacokinetics of GST-HG141 in Patients With Chronic Hepatitis B (CHB) Who Have an Inadequate Response to Antiviral Drug TreatmentWho this might be right forChronic Hepatitis b Fujian Akeylink Biotechnology Co., Ltd. 526
Large-scale testing (Phase 3)Study completedNCT00977106What this trial is testingTORPEDO Study: A Study on Rapid Effect of Tocilizumab in Patients With Rheumatoid Arthritis With an Inadequate Response to Disease-Modifying Antirheumatic Drugs (DMARDs) or Anti-TNFWho this might be right forRheumatoid Arthritis Hoffmann-La Roche 103
Post-approval studies (Phase 4)UnknownNCT04843423What this trial is testingAdjunct Treatment With Cariprazine for Adults With Attention-deficit/Hyperactivity DisorderWho this might be right forAttention Deficit Hyperactivity Disorder Dr. Martin A. Katzman 15
Testing effectiveness (Phase 2)Ended earlyNCT01288079What this trial is testingAssess the Safety and Effect of TC-5214 in Patients With Major Depressive Disorder.Who this might be right forMajor Depressive Disorder AstraZeneca 145